People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Biotechnology, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biodesix Inc | — | Biotechnology | Series B | $175.4M | $635.0M | 2018 |
| Eximis Surgical Inc. | — | Medical Devices | Series B | $40.6M | $160.3M | 2018 |
Scott Hutton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Hutton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| Mark Miller | 1 | 18 |
| Scott Button | 1 | 4 |
| MICHAEL KRAMER | 1 | 3 |
| Matthew Strobeck | 1 | 3 |
| Robin Cowie | 1 | 3 |
| Frank Ronchetti | 1 | 2 |
| David Brunel | 1 | 2 |
| Jack Schuler | 1 | 2 |
| Theodore Lamson | 1 | 2 |
| John Patience | 1 | 2 |
| Robert Cawthorn | 1 | 2 |
| Kristin Johnson | 1 | 1 |
| William Gregg | 1 | 1 |
| Donna Ford-Serbu | 1 | 1 |
| Dirk Johnson | 1 | 1 |
| Heinrich Roder, D.Phil. | 1 | 1 |
| Brian Butler | 1 | 1 |
| Michael Blomeyer | 1 | 1 |
| Jean Franchi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.